Navigation Links
CfPIE’s Newest Training Course Facilitates Life Science Professionals in Staying Current with FDA Approval Trends
Date:12/18/2012

Malvern, PA (PRWEB) December 18, 2012

The Center for Professional Innovation and Education (CfPIE) has introduced a new course, Recent FDA Approval Trends: What You Must Know, to help pharmaceutical and biotechnology professionals stay abreast of evolving regulatory trends. The comprehensive, two-day course will be presented on January 28-29, 2012 at the Doubletree Valley Forge in King of Prussia, Pennsylvania.

Addressed are cost-effective strategies and tactics for keeping track of developments in FDA approvals and the latest requirements in a complex regulatory environment to avoid the consequences of non-compliance. It breaks down information compiled from the Tufts Center for the Study of Drug Development (Tufts CSDD) and from consultant and government reports into perspectives for individuals working across a broad range of disciplines. This content holds particular importance for those in clinical development, translational medicine, regulatory science, regulatory affairs, risk management, clinical/regulatory informatics, statistics, strategic planning, and project management.

The curriculum covers current trends and provides insights into how they translate into the future. It also compares tactics adopted by competitors as well as trend variations within therapeutic areas and product types. Key topics include basic approval trends for NMEs, NDAs, BLAs, and Supplements; special product designations/programs; regulatory science and ‘next wave’ product approvals; the impact of FDA and Sponsor workload on approval trends; factors that may introduce bias into the approval process; and what PDUFA’s past tells us about its future.

About CfPIE
The Center for Professional Innovation and Education (CfPIE) is the global leader in profess
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Two Baltimore Business Leaders are BioHealth Innovation, Inc.s Newest Board Members
2. Clinical Site Services Chris Trizna Contributing Author in Diana Anderson-Fosters Newest Release Global Issues in Patient Recruitment and Retention
3. Vision Research Introduces the Newest Member Of the Phantom®- 1Mpx- v-Series Camera Family
4. Autoimmune disease retraining white blood cells
5. Veridiams Training Program Wins Accolades and Awards- Meets Skilled Labor Challenge Head On
6. Queens Volunteer Firefighters Receive Mold Removal Training; IgotMold Recommends Use of Molderizer to Make the Process Effective and Safe
7. NPL named by Semta as a top training provider
8. Online Training for Hospital Value Based Purchasing Now Available
9. The Spring 2012 MediSend Biomedical Repair Training Program™ Sends Graduating Biomedical Technicians to Hospitals Around the World
10. Covenant Security Services and the Department of Homeland Security Partner to Provide Nationwide Training on Active Shooter Awareness and Response
11. Fluke Biomedical training center goes global: adds multi-language support
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015 Sinovac Biotech Ltd. (Nasdaq: ... today announced its unaudited financial results for the fourth ... Fourth Quarter 2014 Financial Highlights(Compared to the fourth ... million, a decrease of 11.4% from $22.9 million in ... stockpiling of H5N1 pandemic influenza vaccine of $0.1 million ...
(Date:4/17/2015)... , April 17, 2015  Centrillion Technologies, ... SBIR grant from the National Human Genome ... of Health (NIH). The grant will help ... the development of breakthrough genomic technologies, including ... fabricated substrates. Centrillion has been developing this ...
(Date:4/17/2015)... , April 17, 2015  US-Australian drug discovery ... a Memorandum of Understanding with the Feinstein Institute ... New York to collaborate with the ... The collaboration brings together the drug ... clinical expertise of the Feinstein Institute in neurosciences ...
(Date:4/16/2015)... OSAKA, Japan , April 16, ... (CiRA) of Kyoto University and Takeda Pharmaceutical Company ... together to develop clinical applications of induced pluripotent ... diabetes mellitus, neurological disorders and cancer immunotherapy. The ... is designed to expedite multiple research projects for ...
Breaking Biology Technology:Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 3Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 4Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 5Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 7Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 8Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 9Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 10Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 11Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 12Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 13Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 14Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 15Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 16Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 17Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 18Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3
... Trial Data at the American Heart Association Late Breaker Session ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
... Novel Orally Active Anti-Cancer Compounds at Major Conference in Germany ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by ...
... , WEST LAFAYETTE, Ind. - Researchers have demonstrated ... called single-wall carbon nanotubes, possibly hastening their use ... electronics that are faster and consume less power ... used to revolutionize electronics by replacing conventional silicon ...
Cached Biology Technology:Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 2Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 3Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 4Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 5Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 6Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 7Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 8Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 9Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 10Aeterna Zentaris Presents Encouraging Preclinical Data on Two Novel Orally Active Anti-Cancer Compounds at Major Conference in Germany 2Aeterna Zentaris Presents Encouraging Preclinical Data on Two Novel Orally Active Anti-Cancer Compounds at Major Conference in Germany 3Aeterna Zentaris Presents Encouraging Preclinical Data on Two Novel Orally Active Anti-Cancer Compounds at Major Conference in Germany 4Aeterna Zentaris Presents Encouraging Preclinical Data on Two Novel Orally Active Anti-Cancer Compounds at Major Conference in Germany 5Aeterna Zentaris Presents Encouraging Preclinical Data on Two Novel Orally Active Anti-Cancer Compounds at Major Conference in Germany 6Aeterna Zentaris Presents Encouraging Preclinical Data on Two Novel Orally Active Anti-Cancer Compounds at Major Conference in Germany 7Aeterna Zentaris Presents Encouraging Preclinical Data on Two Novel Orally Active Anti-Cancer Compounds at Major Conference in Germany 8Aeterna Zentaris Presents Encouraging Preclinical Data on Two Novel Orally Active Anti-Cancer Compounds at Major Conference in Germany 9Imaging tool may aid nanoelectronics by screening tiny tubes 2Imaging tool may aid nanoelectronics by screening tiny tubes 3
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... the "Global Gesture Recognition Market in Automotive Sector ... analysts forecast the Global Gesture Recognition market in Automotive ... the period 2013-2018. Gesture recognition is the ... different gestures of an individual. Gesture recognition technology can ...
(Date:3/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) ... Recognition Market 2015-2019" report to their offering. ... to grow at a CAGR of 23.5 percent over ... present scenario and the growth prospects of the Global ... the market size, the report considers the revenue generated ...
(Date:3/24/2015)... 2015   NexID Biometrics LLC, whose spoof-mitigation ... today announced the beginning of shipments of version 2.0 ... The company, based in Potsdam, N.Y. ... Expo, which began here today at the Walter E. ... of its SDK boosts the accuracy rate range to ...
Breaking Biology News(10 mins):Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... survival and that of most other animals on earth. It ... discretely embedded into our everyday lives. Plants provide us with ... spite of their importance, very few of us could name ... us. True, most would have little difficulty in distinguishing between ...
... the Conservation Reserve Program (CRP) in the United States ... Questions abound regarding the fate of carbon sequestered in ... if the land is converted to grain crop production ... conserve the sequestered soil organic carbon (SOC). The effect ...
... 2009) - Researchers of the Michael G. DeGroote Institute ... that bacteria evolve into something that can make you ... issue of the Proceedings of the National Academy ... and assign risk to emerging diseases in the environment. ...
Cached Biology News:Will large amounts of soil carbon be released if grasslands are converted to energy crops? 2McMaster researchers discover new mode of how diseases evolve 2
... premium quality recombinant form of Thermus aquaticus ... for a wide range of PCR applications. ... performance, each preparation is extensively tested in ... DNA Polymerase possesses an integral 5′→3′ exonuclease ...
Mouse polyclonal antibody raised against a partial recombinant TSEN2. NCBI Entrez Gene ID = 80746...
Mouse polyclonal antibody raised against a partial recombinant NCLN. NCBI Entrez Gene ID = 56926...
Mouse monoclonal antibody raised against a partial recombinant FBXO11. NCBI Entrez Gene ID = FBXO11...
Biology Products: